MYCHEL-S Drug Patent Profile
✉ Email this page to a colleague
When do Mychel-s patents expire, and what generic alternatives are available?
Mychel-s is a drug marketed by Angus and is included in one NDA.
The generic ingredient in MYCHEL-S is chloramphenicol sodium succinate. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chloramphenicol sodium succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mychel-s
A generic version of MYCHEL-S was approved as chloramphenicol sodium succinate by FRESENIUS KABI USA on August 25th, 1982.
Summary for MYCHEL-S
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYCHEL-S at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYCHEL-S
US Patents and Regulatory Information for MYCHEL-S
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angus | MYCHEL-S | chloramphenicol sodium succinate | INJECTABLE;INJECTION | 060132-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |